These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 33967344)
21. Inhibitory mechanism of clioquinol and its derivatives at the exopeptidase site of human angiotensin-converting enzyme-2 and receptor binding domain of SARS-CoV-2 viral spike. Kehinde IA; Egbeyemi A; Kaur M; Onyenaka C; Adebusuyi T; Olaleye OA J Biomol Struct Dyn; 2023 Apr; 41(7):2992-3001. PubMed ID: 35220925 [TBL] [Abstract][Full Text] [Related]
22. Proposing a fungal metabolite-flaviolin as a potential inhibitor of 3CL Rao P; Shukla A; Parmar P; Rawal RM; Patel BV; Saraf M; Goswami D J Biomol Struct Dyn; 2022 Jan; 40(1):348-360. PubMed ID: 32875950 [TBL] [Abstract][Full Text] [Related]
23. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. Kumar Y; Singh H; Patel CN J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274 [TBL] [Abstract][Full Text] [Related]
25. Antiviral phytocompounds "ellagic acid" and "(+)-sesamin" of Umar AK; Zothantluanga JH; Aswin K; Maulana S; Sulaiman Zubair M; Lalhlenmawia H; Rudrapal M; Chetia D Struct Chem; 2022; 33(5):1445-1465. PubMed ID: 35571865 [TBL] [Abstract][Full Text] [Related]
26. In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2. Bhattacharya K; Bordoloi R; Chanu NR; Kalita R; Sahariah BJ; Bhattacharjee A J Genet Eng Biotechnol; 2022 Mar; 20(1):43. PubMed ID: 35262828 [TBL] [Abstract][Full Text] [Related]
27. Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study. Ibrahim MAA; Mohamed EAR; Abdelrahman AHM; Allemailem KS; Moustafa MF; Shawky AM; Mahzari A; Hakami AR; Abdeljawaad KAA; Atia MAM J Mol Graph Model; 2021 Jun; 105():107904. PubMed ID: 33798836 [TBL] [Abstract][Full Text] [Related]
28. The interaction of the bioflavonoids with five SARS-CoV-2 proteins targets: An in silico study. Mishra GP; Bhadane RN; Panigrahi D; Amawi HA; Asbhy CR; Tiwari AK Comput Biol Med; 2021 Jul; 134():104464. PubMed ID: 34020130 [TBL] [Abstract][Full Text] [Related]
29. Teli DM; Shah MB; Chhabria MT Front Mol Biosci; 2020; 7():599079. PubMed ID: 33542917 [TBL] [Abstract][Full Text] [Related]
30. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2. Abdizadeh R; Hadizadeh F; Abdizadeh T Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728 [TBL] [Abstract][Full Text] [Related]
32. Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation. Bepari AK; Reza HM PeerJ; 2021; 9():e11261. PubMed ID: 33954055 [TBL] [Abstract][Full Text] [Related]
33. Structure-based virtual screening of bioactive compounds from Indonesian medical plants against severe acute respiratory syndrome coronavirus-2. Gani MA; Nurhan AD; Maulana S; Siswodihardjo S; Shinta DW; Khotib J J Adv Pharm Technol Res; 2021; 12(2):120-126. PubMed ID: 34159141 [TBL] [Abstract][Full Text] [Related]
34. COVID-19: docking-based virtual screening and molecular dynamics study to identify potential SARS-CoV-2 spike protein inhibitors from plant-based phenolic compounds. Moradkhani S; Farmani A; Saidijam M; Taherkhani A Acta Virol; 2021; 65(3):288-302. PubMed ID: 34565157 [TBL] [Abstract][Full Text] [Related]
35. Screening potential FDA-approved inhibitors of the SARS-CoV-2 major protease 3CL Liu WS; Li HG; Ding CH; Zhang HX; Wang RR; Li JQ Aging (Albany NY); 2021 Mar; 13(5):6258-6272. PubMed ID: 33678621 [TBL] [Abstract][Full Text] [Related]
36. Identifying the natural compound Catechin from tropical mangrove plants as a potential lead candidate against 3CL Jha RK; Khan RJ; Parthiban A; Singh E; Jain M; Amera GM; Singh RP; Ramachandran P; Ramachandran R; Sachithanandam V; Muthukumaran J; Singh AK J Biomol Struct Dyn; 2022; 40(24):13392-13411. PubMed ID: 34644249 [TBL] [Abstract][Full Text] [Related]
37. Study on the mechanism of active components of Liupao tea on 3CL Ni WJ; Chen XX; Wei SY; Lan LL; Qiu RJ; Ling YP; Zhou DS; Wu ZM; Cao ZH; Yu CP; Zeng Y J Food Biochem; 2021 May; 45(5):e13707. PubMed ID: 33760271 [TBL] [Abstract][Full Text] [Related]
38. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors. Ibrahim MAA; Abdelrahman AHM; Hussien TA; Badr EAA; Mohamed TA; El-Seedi HR; Pare PW; Efferth T; Hegazy MF Comput Biol Med; 2020 Nov; 126():104046. PubMed ID: 33065388 [TBL] [Abstract][Full Text] [Related]
39. QSAR, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective benzotriazole-based SARS-CoV 3CL protease inhibitors. D'Souza S; Balaji S; K V P J Biomol Struct Dyn; 2022; 40(24):14247-14261. PubMed ID: 34877897 [TBL] [Abstract][Full Text] [Related]
40. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19. Vardhan S; Sahoo SK Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]